| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.2M | +9.2% | -6.5% |
| Cost of Revenue | $5.5M | +17.8% | +2.0% |
| Gross Profit | $9.6M | +4.8% | -10.8% |
| R&D Expense | $0 | — | -100.0% |
| SG&A Expense | $5.1M | +3.0% | +14.0% |
| Operating Income | -$2.0M | -31.0% | -16.2% |
| Pre-tax Income | -$10.6M | -638.6% | -2870.7% |
| Income Tax | $0 | — | +100.0% |
| Net Income | -$10.6M | -638.6% | -1443.1% |
| EPS (Basic) | -$1.05 | -600.0% | -907.7% |
| EPS (Diluted) | -$1.05 | -1212.5% | -303.8% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $30.0M | -8.0% | +47.2% |
| Accounts Receivable | $30.9M | -6.9% | +21.7% |
| Inventory | $8.7M | -14.3% | -21.9% |
| Current Assets | $76.2M | -6.0% | — |
| Total Assets | $122.0M | -2.4% | +5.0% |
| Current Liabilities | $65.6M | -0.7% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.1M | +594.7% | — |
| Capital Expenditures | $17K | — | — |
| Investing Cash Flow | -$17K | — | — |
| Financing Cash Flow | -$4.0M | -272.8% | — |
| Free Cash Flow | $3.0M | +591.9% | — |
| +2.4% |
| Long-term Debt | $10.0M | -4.3% | +0.2% |
| Stockholders' Equity | $14.2M | -38.7% | -53.8% |